Sanofi inks deal for Poland's Nepentes

Sanofi-Aventis (NYSE: SNY) unveiled a further push into emerging markets with plans to buy Polish consumer healthcare group Nepentes in a deal valuing it at around 105 million euros ($130.4 million). Release | Report